Skip to main content

Together we are beating cancer

Donate now

Human papillomavirus (HPV)

Showing 12 out of 61 results
Headshots of Dame Valerie Beral, Anne Szarewski, Nandita deSouza and Yvonne Barr

As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

by Amy Warnock | In depth | 25 January 2023

25 January 2023

CRUK and UICC’s Tobacco Control Partnership in Kenya and Uganda is launched at the World Cancer Congress
  • Health & Medicine
  • Policy & Insight

Reflections from the World Cancer Congress

Across the diverse audience of cancer researchers, health policy professionals, government officials and cancer survivors there was a common desire at the World Cancer Congress: to make up for lost time.  Across the diverse audience of cancer researchers, health policy professionals, government officials and cancer survivors there was a common desire at the World Cancer Congress: to make up for lost time. 

by George Hayes | Analysis | 30 November 2022

30 November 2022

This entry is part 3 of 3 in the series CRUK Global
A bottle containing the HPV vaccine

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

by Lilly Matson | In depth | 21 November 2022

21 November 2022

A patient receiving chemotherapy

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

by Jacob Smith | News | 2 May 2022

2 May 2022

That Cancer Conversation in a white speech bubble with a dark blue background

Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer. Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer.

by Cancer Research UK | Podcast | 9 December 2021

9 December 2021

This entry is part 4 of 22 in the series That Cancer Conversation
A photograph of a lady holding a vaccine and needle.

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide. We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

by Lilly Matson | In depth | 17 November 2021

17 November 2021

It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide. It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide.

by Rachel Orritt | Analysis | 25 October 2021

25 October 2021

Two people's feet in bed.

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses. We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

by Karis Betts | Analysis | 16 June 2021

16 June 2021

Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem. Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem.

by Lilly Matson | Analysis | 19 April 2021

19 April 2021

HPV vaccine

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

by Cancer Research UK | News | 1 October 2020

1 October 2020